MARKET

PRGO

PRGO

Perrigo Company
NYSE

Real-time Quotes | Nasdaq Last Sale

43.35
+0.35
+0.81%
After Hours: 43.35 0 0.00% 16:00 09/27 EDT
OPEN
43.17
PREV CLOSE
43.00
HIGH
43.89
LOW
43.17
VOLUME
886.12K
TURNOVER
--
52 WEEK HIGH
49.91
52 WEEK LOW
38.20
MARKET CAP
5.80B
P/E (TTM)
-13.3728
1D
5D
1M
3M
1Y
5Y
The past five years for Perrigo (NYSE:PRGO) investors has not been profitable
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
Simply Wall St. · 2h ago
Match Group dips following S&P 500 inclusion
Match Group (MTCH -2.1%) trades down following its inclusion in the S&P 500 today. The stock surged 11% on Sept 3 following the announcement that it, software company Ceridian HCM Holding
Seekingalpha · 09/20 14:01
Why Is Perrigo (PRGO) Up 7.1% Since Last Earnings Report?
Zacks.com · 09/10 15:30
Perrigo (PRGO) to Acquire Another Self-Care Company HRA Pharma
Perrigo (PRGO) offers to acquire HRA Pharma with several leading OTC brands in its portfolio for almost $2.1 billion. The acquisition will complete Perrigo's transformation into a leading self-care company.
Zacks · 09/09 14:10
Wall Street ends lower, weighed down by Big Tech
Wall Street ended lower on Wednesday, spooked by worries that the Delta coronavirus variant could blunt the economy's recovery and on uncertainty about when the Federal Reserve may pull back its accommodative policies.
Reuters · 09/08 23:37
Why Perrigo's Stock Is Trading Higher Today
Perrigo Company plc (NYSE: PRGO) shares are trading higher after the company announced it will acquire HRA Pharma for $2.1 billion in cash. "The acquisition of HRA would be the crowning achievement in that transformation. With the addition of HRA and its t...
Benzinga · 09/08 19:56
Perrigo Agrees to Buy Hera for $2.1 Billion in Cash
Perrigo is buying Hera from funds affiliated with private equity firm Astorg and Goldman Sachs Asset Management.
TheStreet.com · 09/08 17:20
Perrigo to buy HRA Pharma in $2.1 billion deal to expand self-care portfolio
Perrigo Company Plc said on Wednesday it would buy HRA Pharma from investment firms Astorg and Goldman Sachs Asset Management in a deal valued at 1.8 billion euros ($2.13 billion) to bolster its over-the-counter self-care offerings, sending its shares up 6...
Reuters · 09/08 14:53
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of PRGO. Analyze the recent business situations of Perrigo Company through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average PRGO stock price target is 51.00 with a high estimate of 60.00 and a low estimate of 45.00.
EPS
Institutional Holdings
Institutions: 471
Institutional Holdings: 138.52M
% Owned: 103.59%
Shares Outstanding: 133.71M
TypeInstitutionsShares
Increased
107
6.78M
New
44
3.19M
Decreased
99
5.16M
Sold Out
59
2.13M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.74%
Pharmaceuticals & Medical Research
-0.92%
Key Executives
Non-Executive Chairman/Independent Director
Rolf Classon
President/Chief Executive Officer/Director
Murray Kessler
Chief Financial Officer/Executive Vice President
Raymond Silcock
Chief Human Resource Officer/Executive Vice President
Robert Willis
Executive Vice President/Chief Information Officer
Thomas Farrington
Executive Vice President/Chief Scientific Officer
James Dillard
Executive Vice President/General Counsel/Secretary
Todd Kingma
Executive Vice President/General Manager
Richard Sorota
Executive Vice President
Svend Andersen
Executive Vice President
Ronald Janish
Executive Vice President
Sharon Kochan
Executive Vice President
Grainne Quinn
Independent Director
Bradley Alford
Independent Director
Orlando Ashford
Independent Director
Katherine Doyle
Independent Director
Adriana Karaboutis
Independent Director
Jeffrey Kindler
Independent Director
Erica Mann
Independent Director
Donal O'Connor
Independent Director
Geoffrey Parker
Independent Director
Theodore Samuels
Declaration Date
Dividend Per Share
Ex-Div Date
08/03/2021
Dividend USD 0.24
09/02/2021
--
Dividend USD 0.24
06/03/2021
02/23/2021
Dividend USD 0.24
03/11/2021
10/22/2020
Dividend USD 0.225
11/25/2020
07/29/2020
Dividend USD 0.225
08/27/2020
05/05/2020
Dividend USD 0.225
05/28/2020
02/18/2020
Dividend USD 0.225
02/27/2020
11/04/2019
Dividend USD 0.21
11/27/2019
07/31/2019
Dividend USD 0.21
08/29/2019
04/26/2019
Dividend USD 0.21
05/30/2019
02/14/2019
Dividend USD 0.19
02/28/2019
10/31/2018
Dividend USD 0.19
11/29/2018
08/01/2018
Dividend USD 0.19
08/30/2018
05/03/2018
Dividend USD 0.19
05/31/2018
02/15/2018
Dividend USD 0.19
03/01/2018
11/02/2017
Dividend USD 0.16
11/30/2017
08/08/2017
Dividend USD 0.16
08/23/2017
05/03/2017
Dividend USD 0.16
05/24/2017
02/21/2017
Dividend USD 0.16
03/01/2017
11/08/2016
Dividend USD 0.145
11/22/2016
  • All
  • Financials
  • Insiders
More
About PRGO
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that enables consumers to prevent or treat conditions that can be self-managed. The Company operates through two segments: Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises consumer self-care business (OTC, infant formula, and oral self-care categories, and contract manufacturing) in the United States (U.S), Mexico and Canada. CSCA segment products sold under brands, such as Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod and Firefly. The CSCI segment comprises consumer self-care business primarily branded in Europe and Australia, store brand business in the United Kingdom and parts of Europe and Asia. The CSCI segment primarily focuses on building local and regional brands sold through merchandisers, drug stores, pharmacies and e-commerce channels.

Webull offers kinds of Perrigo Company PLC stock information, including NYSE:PRGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRGO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PRGO stock methods without spending real money on the virtual paper trading platform.